dsip-austin-tx Home ICYMI: @TxDPS Hosts Annual Uniformed
Description
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
Duis vitae erat vitae turpis cursus pretium
Batch-specific COAs are available on the product page
Ilic S, Drmic D, Zarkovic K, Kolenc D, Coric M, Brcic L, et al
